A Bernese spine surgeon stands accused of causing serious bodily harm after implanting a novel prosthesis with limited testing in seven patients, sparking a courtroom drama that questions medical ethics and patient safety. The Bern public prosecutor’s office alleges that Max Aebi, the surgeon, failed to adequately inform patients about the risks associated with the device, which he helped develop.
Aebi, who last publicly addressed the allegations seven years ago, remained silent during proceedings on January 16th, responding to all questions from the judge with a simple: “I don’t make any statement about it.” His lawyer has previously asserted that Aebi “behaved correctly both legally and professionally.”
What Should Patients Know Before Surgery?
The trial has brought to light critical questions about informed consent and transparency in medical innovation. Experts testifying before the court emphasized the importance of fully disclosing potential complications and conflicts of interest.
Balgrist chief physician and spine specialist Mazda Farshad testified that the prosthesis had failed during animal trials. “The prosthesis didn’t work on the monkeys,” he stated. “It probably would have been a sensible sentence to say, we did a monkey experiment and we had bad results. Then we wouldn’t be sitting in this courtroom right now.” Farshad also stressed the need for surgeons to disclose any involvement they have with the development or manufacturing of a medical product, stating, “If you work with a company and use a product to which you have contributed in some way, then you should mention that in an educational discussion.” He added that Aebi should have at least mentioned “the five most common and most serious possible complications.”
The manufacturer recalled the prosthesis in 2014 due to serious defects, and medical ethicist Tanja Krones emphasized that informing patients about a recall is an “ethical duty.” Krones further argued that disclosing conflicts of interest is crucial, explaining that “It makes a difference whether you receive a fee on an hourly basis or stocks where you bet that there will be a profit.” She suggested that Aebi should have involved another doctor “who doesn’t have these interests.”
Patients who received the implant expressed feelings of betrayal and a lack of transparency. One patient stated, “The way he acted, I believed he was independent.” Another said, “He never mentioned his financial holdings.” A 24-year-old patient recalled, “I was 24 years old and happy that I was taken seriously. When he suggested the implant, I immediately said yes.”
Even Aebi’s assistant doctor, responsible for patient education, was unaware of the implant’s novelty and the lack of long-term data, as well as the professor’s involvement in its development.
A verdict in the case is expected on February 9th. Aebi is presumed innocent until proven guilty, and his lawyer is expected to present a plea in the coming days.
What are the key issues in the Max Aebi trial? The case centers on allegations of serious bodily harm stemming from the implantation of a poorly tested prosthesis, raising questions about informed consent, transparency, and potential conflicts of interest in medical innovation.
